Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Reproductive Health Funding topic
No spam. Unsubscribe anytime.
Senate Appropriations reviews $100,000 Planned Parenthood grant for medication abortion drugs
Summary
The Department of Health asked the Senate Appropriations Committee to add $100,000 in general funds so Planned Parenthood of Northern New England can stock medications used for medication abortion; the department described the payment as a one-year stock though later comments suggested supply might last longer.
The Vermont Department of Health asked the Senate Appropriations Committee on Jan. 21 to approve a $100,000 general fund appropriation to Planned Parenthood of Northern New England to purchase medications used for medication abortion.
The department’s presentation said, “This will provide a 1 year stock of the 2 medications that are used for medication abortion, which are mifepristone and misoprostol. And that will assure uninterrupted access to care for patients,” Commissioner Mark Levine said.
The department framed the request as a time-limited stocking measure intended to keep care uninterrupted amid regulatory uncertainty. Levine said the department had made a similar purchase in 2023 and cited concern about changes in the federal regulatory environment as a reason to ensure local availability of the medicines.
Committee members asked how long the donated supply would last. The presenter initially described the purchase as a one-year stock; later in the discussion the department staff said their understanding was the shipment would last about two years but did not present a single definitive estimate.
The department did not identify a different funding source for the purchase; members confirmed the request was for general fund dollars. No formal vote or final committee action on the appropriation appears in the transcript.
The presentation did not specify whether the department or Planned Parenthood would bill Medicaid or other payers for medications purchased with the appropriation; a committee member asked whether Medicaid could cover any of the cost and was told that the department had not discussed that specific billing approach with Agency of Human Services central office and that the survey directive was a Vermont law matter intended to serve the whole population.
Committee members asked the department to provide follow-up details on the expected duration of the stocked medications and any billing or reimbursement plans.
The committee continued with other items after the department finished its presentation.
